343 related articles for article (PubMed ID: 37389459)
1. Understanding the gut microbiota in cancer cachexia.
Rocha IM; Fonseca DC; Torrinhas RSM; Waitzberg DL
Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):482-489. PubMed ID: 37389459
[TBL] [Abstract][Full Text] [Related]
2. Targeting Gut Microbiota in Cancer Cachexia: Towards New Treatment Options.
Panebianco C; Villani A; Potenza A; Favaro E; Finocchiaro C; Perri F; Pazienza V
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768173
[TBL] [Abstract][Full Text] [Related]
3. The Microbiota and Cancer Cachexia.
Herremans KM; Riner AN; Cameron ME; Trevino JG
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842339
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders.
Sankararaman S; Noriega K; Velayuthan S; Sferra T; Martindale R
Curr Gastroenterol Rep; 2023 Feb; 25(2):31-44. PubMed ID: 36469257
[TBL] [Abstract][Full Text] [Related]
5. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
Wei Y; Peng S; Lian C; Kang Q; Chen J
Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
[TBL] [Abstract][Full Text] [Related]
7. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
[TBL] [Abstract][Full Text] [Related]
8. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
[TBL] [Abstract][Full Text] [Related]
9. Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics.
Rani V; Singhal S; Sharma K; Vaid R; Aggarwal K; Bhadana R; Agarwal R; Atale N
Curr Pharm Des; 2021; 27(45):4578-4592. PubMed ID: 34620056
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Gut Microbiota to Treat Cachexia.
Genton L; Mareschal J; Charretier Y; Lazarevic V; Bindels LB; Schrenzel J
Front Cell Infect Microbiol; 2019; 9():305. PubMed ID: 31572686
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiome-targeted therapies for Alzheimer's disease.
Zhang T; Gao G; Kwok LY; Sun Z
Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
[TBL] [Abstract][Full Text] [Related]
12. Probiotics, prebiotics, synbiotics, and fecal microbiota transplantation in the treatment of behavioral symptoms of autism spectrum disorder: A systematic review.
Tan Q; Orsso CE; Deehan EC; Kung JY; Tun HM; Wine E; Madsen KL; Zwaigenbaum L; Haqq AM
Autism Res; 2021 Sep; 14(9):1820-1836. PubMed ID: 34173726
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota and metabolic aspects of cancer cachexia.
Ziemons J; Smidt ML; Damink SO; Rensen SS
Best Pract Res Clin Endocrinol Metab; 2021 May; 35(3):101508. PubMed ID: 33648847
[TBL] [Abstract][Full Text] [Related]
14. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A
Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636
[TBL] [Abstract][Full Text] [Related]
15. Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.
Chowdhury M; Raj Chaudhary N; Kaur P; Goyal A; Sahu SK
Infect Disord Drug Targets; 2024; 24(5):e160124225675. PubMed ID: 38317473
[TBL] [Abstract][Full Text] [Related]
16. Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis.
Ullah H; Tovchiga O; Daglia M; Khan H
Curr Neuropharmacol; 2021; 19(11):1966-1983. PubMed ID: 33596808
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota.
Flaig B; Garza R; Singh B; Hamamah S; Covasa M
Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615885
[TBL] [Abstract][Full Text] [Related]
18. Overview of the Importance of Biotics in Gut Barrier Integrity.
Kocot AM; Jarocka-Cyrta E; Drabińska N
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
[TBL] [Abstract][Full Text] [Related]
19. Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia.
Bindels LB; Neyrinck AM; Claus SP; Le Roy CI; Grangette C; Pot B; Martinez I; Walter J; Cani PD; Delzenne NM
ISME J; 2016 Jun; 10(6):1456-70. PubMed ID: 26613342
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota and Complications of Type-2 Diabetes.
Iatcu CO; Steen A; Covasa M
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
